Benjamin Kornitzer - Sep 14, 2021 Form 4 Insider Report for agilon health, inc. (AGL)

Role: Chief Med. & Quality Officer
Signature: /s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Stock symbol: AGL
Transactions as of: Sep 14, 2021
Transactions value $: -$280,908
Form type: 4
Date filed: 9/15/2021, 05:19 PM
Next filing: Sep 29, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGL	Common Stock	Options Exercise	$51.6K	+11.5K	+211.17%	$4.50^*	16.9K	Sep 14, 2021	Direct	F1
transaction	AGL	Common Stock	Sale	-$333K	-11.5K	-67.86%	$28.98	5.43K	Sep 14, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGL	Options (Rights to Buy)	Options Exercise	$0	-11.5K	-2.09%	$0.00	539K	Sep 14, 2021	Common Stock	11.5K	$4.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes restricted stock units.
F2	These options were granted on January 31, 2020. 25% of the options vested on January 9, 2021 and the remaining options are scheduled to vest in three equal installments on each anniversary of January 9, 2021, subject to continued employment.